Evidence map›Paper›PMID 26626552›Full record

GuidelineHerz2015

[ESC guidelines 2015 for ventricular arrhythmias and prevention of sudden cardiac death. What is new?].

T Fink, K H Kuck, A Metzner, European Society of Cardiology

Abstract readEnglish AbstractPractice Guideline
PubMed Publisher
In one paragraph

Guideline in Herz, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 90% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

T FinkAbteilung für Kardiologie, Asklepios Klinik St. Georg, 20099, Hamburg, Lohmühlenstraße 5, Deutschland.
K H KuckAbteilung für Kardiologie, Asklepios Klinik St. Georg, 20099, Hamburg, Lohmühlenstraße 5, Deutschland.
A MetznerAbteilung für Kardiologie, Asklepios Klinik St. Georg, 20099, Hamburg, Lohmühlenstraße 5, Deutschland. a.metzner@asklepios.com.
European Society of Cardiology
Asklepios Klinik St. Georg · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The new European Society of Cardiology (ESC) guidelines for the management of patients with ventricular arrhythmia and the prevention of sudden cardiac death, recently published at the annual ESC meeting in London, contain an extensive update of the recommendations for the diagnostics, drug therapy, interventional and device therapy of ventricular arrhythmia. The new recommendations for implantable cardioverter defibrillator (ICD) treatment for primary and secondary prophylaxis of sudden cardiac death can be seen as a focused update of the previously published guidelines. Pre-existing recommendations for catheter ablation of ventricular arrhythmias have been partly extensively expanded with respect to the results of recent clinical trials. The guideline committee also adapted their recommendations regarding the hereditary arrhythmia syndromes to the 2013 consensus report of the American Heart Association (AHA), the European Heart Rhythm Association (EHRA) and the Asia Pacific Heart Rhythm Society (APHRS).

Indexed as

CardiologyCatheter AblationDeath, Sudden, CardiacDefibrillators, ImplantableEuropeEvidence-Based MedicineHumansTachycardia, VentricularTreatment OutcomeVentricular FibrillationCatheter ablationImplantable cardioverter defibrillatorSudden cardiac deathTachycardiaVentricular arrhythmia

Identifiers

PMID26626552
OpenAlexW2183997027

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.